127 related articles for article (PubMed ID: 10975836)
21. Functional analysis of the antigen binding region of an MHC class II molecule.
Rosloniec EF; Beard KS; Freed JH
Mol Immunol; 1993 Apr; 30(5):491-501. PubMed ID: 7681933
[TBL] [Abstract][Full Text] [Related]
22. DM determines the cryptic and immunodominant fate of T cell epitopes.
Nanda NK; Sant AJ
J Exp Med; 2000 Sep; 192(6):781-8. PubMed ID: 10993909
[TBL] [Abstract][Full Text] [Related]
23. Two structural states of complexes of peptide and class II major histocompatibility complex revealed by photoaffinity-labeled peptides.
Carrasco-Marín E; Petzold S; Unanue ER
J Biol Chem; 1999 Oct; 274(44):31333-40. PubMed ID: 10531333
[TBL] [Abstract][Full Text] [Related]
24. Molecular modeling of hen egg lysozyme HEL[52-61] peptide binding to I-Ak MHC class II molecule.
Weber P; Raynaud I; Ettouati L; Trescol-Biémont MC; Carrupt PA; Paris J; Rabourdin-Combe C; Gerlier D; Testa B
Int Immunol; 1998 Dec; 10(12):1753-64. PubMed ID: 9885896
[TBL] [Abstract][Full Text] [Related]
25. Cathepsin D, but not cathepsin B, releases T cell stimulatory fragments from lysozyme that are functional in the context of multiple murine class II MHC molecules.
van Noort JM; Jacobs MJ
Eur J Immunol; 1994 Sep; 24(9):2175-80. PubMed ID: 8088334
[TBL] [Abstract][Full Text] [Related]
26. Quantitative analysis of the T cell repertoire that escapes negative selection.
Peterson DA; DiPaolo RJ; Kanagawa O; Unanue ER
Immunity; 1999 Oct; 11(4):453-62. PubMed ID: 10549627
[TBL] [Abstract][Full Text] [Related]
27. Identification of a major I-Ek-restricted determinant of hen egg lysozyme: limitations of lymph node proliferation studies in defining immunodominance and crypticity.
Viner NJ; Nelson CA; Unanue ER
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2214-8. PubMed ID: 7534415
[TBL] [Abstract][Full Text] [Related]
28. Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.
Guéry JC; Sette A; Leighton J; Dragomir A; Adorini L
J Exp Med; 1992 May; 175(5):1345-52. PubMed ID: 1569402
[TBL] [Abstract][Full Text] [Related]
29. Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme.
Brooks A; Hartley S; Kjer-Nielsen L; Perera J; Goodnow CC; Basten A; McCluskey J
Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3290-4. PubMed ID: 1707537
[TBL] [Abstract][Full Text] [Related]
30. Binding of photoreactive lysozyme peptides to murine histocompatibility class II molecules.
Luescher IF; Allen PM; Unanue ER
Proc Natl Acad Sci U S A; 1988 Feb; 85(3):871-4. PubMed ID: 3422468
[TBL] [Abstract][Full Text] [Related]
31. The sites in the I-Ak histocompatibility molecule photoaffinity labeled by an immunogenic lysozyme peptide.
Luescher IF; Crimmins DL; Schwartz BD; Unanue ER
J Biol Chem; 1990 Jul; 265(19):11177-84. PubMed ID: 2358457
[TBL] [Abstract][Full Text] [Related]
32. Myocarditis-inducing epitope of myosin binds constitutively and stably to I-Ak on antigen-presenting cells in the heart.
Donermeyer DL; Beisel KW; Allen PM; Smith SC
J Exp Med; 1995 Nov; 182(5):1291-300. PubMed ID: 7595200
[TBL] [Abstract][Full Text] [Related]
33. T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage.
Carson RT; Vignali KM; Woodland DL; Vignali DA
Immunity; 1997 Sep; 7(3):387-99. PubMed ID: 9324359
[TBL] [Abstract][Full Text] [Related]
34. Appreciating the complexity of MHC class II peptide binding: lysozyme peptide and I-Ak.
Nelson CA; Viner NJ; Unanue ER
Immunol Rev; 1996 Jun; 151():81-105. PubMed ID: 8872486
[No Abstract] [Full Text] [Related]
35. Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope.
Allen PM; Matsueda GR; Evans RJ; Dunbar JB; Marshall GR; Unanue ER
Nature; 1987 Jun 25-Jul 1; 327(6124):713-5. PubMed ID: 2439915
[TBL] [Abstract][Full Text] [Related]
36. Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice.
Latek RR; Suri A; Petzold SJ; Nelson CA; Kanagawa O; Unanue ER; Fremont DH
Immunity; 2000 Jun; 12(6):699-710. PubMed ID: 10894169
[TBL] [Abstract][Full Text] [Related]
37. Comparison of structural requirements for interaction of the same peptide with I-Ek and I-Ed molecules in the activation of MHC class II-restricted T cells.
Leighton J; Sette A; Sidney J; Appella E; Ehrhardt C; Fuchs S; Adorini L
J Immunol; 1991 Jul; 147(1):198-204. PubMed ID: 1711074
[TBL] [Abstract][Full Text] [Related]
38. Threshold detection of self-antigen/MHC class II complexes formed in vivo: constitutive presentation of an immunodominant epitope of hen egg lysozyme (HEL) in HEL-transgenic mice.
Kanost D; Basten A; McCluskey J
Int Immunol; 1993 Aug; 5(8):893-902. PubMed ID: 8398984
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms influencing the immunodominance of T cell determinants.
Adorini L; Appella E; Doria G; Nagy ZA
J Exp Med; 1988 Dec; 168(6):2091-104. PubMed ID: 2462005
[TBL] [Abstract][Full Text] [Related]
40. Tumor cells present MHC class II-restricted nuclear and mitochondrial antigens and are the predominant antigen presenting cells in vivo.
Qi L; Rojas JM; Ostrand-Rosenberg S
J Immunol; 2000 Nov; 165(10):5451-61. PubMed ID: 11067897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
